Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium

International Guideline Harmonization Group ototoxicity group

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

80 Citaten (Scopus)

Samenvatting

Childhood, adolescent, and young adult (CAYA) cancer survivors treated with platinum-based drugs, head or brain radiotherapy, or both have an increased risk of ototoxicity (hearing loss, tinnitus, or both). To ensure optimal care and reduce consequent problems—such as speech and language, social–emotional development, and learning difficulties—for these CAYA cancer survivors, clinical practice guidelines for monitoring ototoxicity are essential. The implementation of surveillance across clinical settings is hindered by differences in definitions of hearing loss, recommendations for surveillance modalities, and remediation. To address these deficiencies, the International Guideline Harmonization Group organised an international multidisciplinary panel, including 32 experts from ten countries, to evaluate the quality of evidence for ototoxicity following platinum-based chemotherapy and head or brain radiotherapy, and formulate and harmonise ototoxicity surveillance recommendations for CAYA cancer survivors.

Originele taal-2Engels
Pagina's (van-tot)e29-e41
TijdschriftThe Lancet Oncology
Volume20
Nummer van het tijdschrift1
DOI's
StatusGepubliceerd - jan. 2019

Vingerafdruk

Duik in de onderzoeksthema's van 'Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium'. Samen vormen ze een unieke vingerafdruk.

Citeer dit